These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 17099035)

  • 1. Exhaled biomarkers.
    Kharitonov SA; Barnes PJ
    Chest; 2006 Nov; 130(5):1541-6. PubMed ID: 17099035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.
    Antus B; Barta I; Kullmann T; Lazar Z; Valyon M; Horvath I; Csiszer E
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1492-7. PubMed ID: 20656939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled breath condensate and airway inflammation.
    Hoffmeyer F; Raulf-Heimsoth M; Brüning T
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):16-22. PubMed ID: 19532089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of exhaled particles from the human lungs in airway obstruction.
    Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled NO and breath condensate.
    Baraldi E; Carraro S
    Paediatr Respir Rev; 2006; 7 Suppl 1():S20-2. PubMed ID: 16798565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath condensate biomarkers in COPD.
    Borrill ZL; Roy K; Singh D
    Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy.
    Shorter JH; Nelson DD; McManus JB; Zahniser MS; Sama SR; Milton DK
    J Breath Res; 2011 Sep; 5(3):037108. PubMed ID: 21757803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
    Deng DD; Zhou AY; Shuang QC; Chen P
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
    [No Abstract]   [Full Text] [Related]  

  • 9. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.
    Santini G; Mores N; Shohreh R; Valente S; Dabrowska M; Trové A; Zini G; Cattani P; Fuso L; Mautone A; Mondino C; Pagliari G; Sala A; Folco G; Aiello M; Pisi R; Chetta A; Losi M; Clini E; Ciabattoni G; Montuschi P
    J Breath Res; 2016 Jan; 10(1):017102. PubMed ID: 26814886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
    Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD.
    Murata K; Fujimoto K; Kitaguchi Y; Horiuchi T; Kubo K; Honda T
    COPD; 2014 Feb; 11(1):81-7. PubMed ID: 24111595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exhaled nitric oxide in the diagnosis and monitoring of lung diseases].
    Antus B; Horváth I
    Orv Hetil; 2007 Jul; 148(27):1251-7. PubMed ID: 17604261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma.
    Muñoz X; Bustamante V; Lopez-Campos JL; Cruz MJ; Barreiro E
    Int Arch Allergy Immunol; 2015; 166(1):1-12. PubMed ID: 25765083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
    Donohue JF; Herje N; Crater G; Rickard K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.
    Kita K; Gawinowska M; Chełmińska M; Niedoszytko M
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.
    Carpagnano GE; Lacedonia D; Carone M; Soccio P; Cotugno G; Palmiotti GA; Scioscia G; Foschino Barbaro MP
    J Breath Res; 2016 Apr; 10(2):026005. PubMed ID: 27063576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of eicosanoids in breath condensate in asthma and COPD.
    Fritscher LG; Post M; Rodrigues MT; Silverman F; Balter M; Chapman KR; Zamel N
    J Breath Res; 2012 Jun; 6(2):026001. PubMed ID: 22451217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation.
    Liu J; Thomas PS
    Med Sci Monit; 2005 Aug; 11(8):MT53-62. PubMed ID: 16049390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.